Enzo Medico

researcher

Enzo Medico is …
instance of (P31):
humanQ5

External links are
P10638Iris-AperTO author ID18255
P496ORCID iD0000-0002-3917-2438
P1053ResearcherIDK-8497-2018
P1153Scopus author ID6602992818

P69educated atUniversity of TurinQ499911
P108employerUniversity of TurinQ499911
Candiolo Cancer InstituteQ30282160
P734family nameMedicoQ37233351
MedicoQ37233351
MedicoQ37233351
P735given nameEnzoQ1346073
EnzoQ1346073
P106occupationresearcherQ1650915
P21sex or gendermaleQ6581097

Reverse relations

author (P50)
Q90493756A Comprehensive PDX Gastric Cancer Collection Captures Cancer Cell-Intrinsic Transcriptional MSI Traits
Q93074969A Genomic Analysis Workflow for Colorectal Cancer Precision Oncology
Q49643002A Molecularly Annotated Model of Patient-Derived Colon Cancer Stem-Like Cells to Assess Genetic and Nongenetic Mechanisms of Resistance to Anti-EGFR Therapy.
Q42745683A New Transgenic Mouse Model of Heart Failure and Cardiac Cachexia Raised by Sustained Activation of Met Tyrosine Kinase in the Heart.
Q91930559A Subset of Colorectal Cancers with Cross-Sensitivity to Olaparib and Oxaliplatin
Q36106540A diphtheria toxin resistance marker for in vitro and in vivo selection of stably transduced human cells
Q40802053A gene trap vector system for identifying transcriptionally responsive genes.
Q58165180A genome-wide trap screening procedure for transcriptionally responsive genes
Q27851787A molecularly annotated platform of patient-derived xenografts ("xenopatients") identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer
Q40094086A novel role of the interferon-inducible protein IFI16 as inducer of proinflammatory molecules in endothelial cells
Q34898364Anti-cancer effect and gene modulation of ET-743 in human biliary tract carcinoma preclinical models
Q28300004BRAF V600E is a determinant of sensitivity to proteasome inhibitors
Q50120184Biochemical and immunological properties of the human carcinoma antigen CAR-5 defined by the monoclonal antibody BD-5.
Q36448373Cancer and blood coagulation.
Q38790312Cardiac concentric hypertrophy promoted by activated Met receptor is mitigated in vivo by inhibition of Erk1,2 signalling with Pimasertib.
Q42183079Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients.
Q98218887Colorectal cancer residual disease at maximal response to EGFR blockade displays a druggable Paneth cell-like phenotype
Q104795307Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts
Q42826953Deregulation of HMGA1 expression induces chromosome instability through regulation of spindle assembly checkpoint genes.
Q36350132Detection of gene communities in multi-networks reveals cancer drivers
Q24311360Differential gene expression induced by insulin and insulin-like growth factor-II through the insulin receptor isoform A
Q42015306Dysregulation of MS risk genes and pathways at distinct stages of disease
Q34543264Efficacy of NEDD8 Pathway Inhibition in Preclinical Models of Poorly Differentiated, Clinically Aggressive Colorectal Cancer
Q39029479Electrical conditioning of adipose-derived stem cells in a multi-chamber culture platform
Q24604601Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer
Q93111962Evolving neoantigen profiles in colorectal cancers with DNA repair defects
Q33338660Exploiting orthologue diversity for systematic detection of gain-of-function phenotypes
Q30478824FLAME, a novel fuzzy clustering method for the analysis of DNA microarray data
Q33941103Formalin fixation at low temperature better preserves nucleic acid integrity.
Q51383543Gender-based blood transcriptomes and interactomes in multiple sclerosis: involvement of SP1 dependent gene transcription.
Q34099059Gene expression profiling uncovers molecular classifiers for the recognition of anaplastic large-cell lymphoma within peripheral T-cell neoplasms
Q35680989Gene trapping: a multi-purpose tool for functional genomics.
Q56688160Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
Q36061792High-throughput molecular analysis from leftover of fine needle aspiration cytology of mammographically detected breast cancer.
Q38332029IGF-II binding to insulin receptor isoform A induces a partially different gene expression profile from insulin binding.
Q41511106IGF2 is an actionable target that identifies a distinct subpopulation of colorectal cancer patients with marginal response to anti-EGFR therapies.
Q49186472IRF4 Mediates the Oncogenic Effects of STAT3 in Anaplastic Large Cell Lymphomas.
Q37344798Identification of p130Cas/ErbB2-dependent invasive signatures in transformed mammary epithelial cells.
Q91264742Increased Lactate Secretion by Cancer Cells Sustains Non-cell-autonomous Adaptive Resistance to MET and EGFR Targeted Therapies
Q39843790Individual cell-based models of cell scatter of ARO and MLP-29 cells in response to hepatocyte growth factor.
Q39564618Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer
Q39680637Inhibition of Src impairs the growth of met-addicted gastric tumors.
Q62678513Integration of transcriptomic data and metabolic networks in cancer samples reveals highly significant prognostic power
Q39095733Interrogating open issues in cancer precision medicine with patient-derived xenografts.
Q37247601Isolation and characterization of a spontaneously immortalized multipotent mesenchymal cell line derived from mouse subcutaneous adipose tissue
Q37672680Loss of AXIN1 drives acquired resistance to WNT pathway blockade in colorectal cancer cells carrying RSPO3 fusions
Q51000683MACC1 mRNA levels predict cancer recurrence after resection of colorectal cancer liver metastases.
Q39978520Met-driven invasive growth involves transcriptional regulation of Arhgap12.
Q36320483MicroRNA-mRNA interactions underlying colorectal cancer molecular subtypes.
Q34034125Mulcom: a multiple comparison statistical test for microarray data in Bioconductor
Q44280495Multipotent mesenchymal stem cells from amniotic fluid originate neural precursors with functional voltage-gated sodium channels
Q39758066Only a subset of Met-activated pathways are required to sustain oncogene addiction
Q39259618PDGFR blockade is a rational and effective therapy for NPM-ALK-driven lymphomas
Q45961634PDX-MI: Minimal Information for Patient-Derived Tumor Xenograft Models.
Q34567461Pathological non-response to chemotherapy in a neoadjuvant setting of breast cancer: an inter-institutional study
Q92376032Patient-Derived Xenografts and Matched Cell Lines Identify Pharmacogenomic Vulnerabilities in Colorectal Cancer
Q91021527Predicting locally advanced rectal cancer response to neoadjuvant therapy with 18F-FDG PET and MRI radiomics features
Q36959186Primary breast cancer stem-like cells metastasise to bone, switch phenotype and acquire a bone tropism signature.
Q48089525Prospective patient stratification into robust cancer-cell intrinsic subtypes from colorectal cancer biopsies
Q24658420Replacement of normal with mutant alleles in the genome of normal human cells unveils mutation-specific drug responses
Q92734518Reverse signaling by semaphorin 4C elicits SMAD1/5- and ID1/3-dependent invasive reprogramming in cancer cells
Q52638232Rituximab Treatment Prevents Lymphoma Onset in Gastric Cancer Patient-Derived Xenografts.
Q34161862Search for neuro-endocrine markers (chromogranin A, synaptophysin and VGF) in breast cancers. An integrated approach using immunohistochemistry and gene expression profiling
Q40953655Selective analysis of cancer-cell intrinsic transcriptional traits defines novel clinically relevant subtypes of colorectal cancer
Q66680700Semalytics: a semantic analytics platform for the exploration of distributed and heterogeneous cancer data in translational research
Q35825970Stimulation of the neurotrophin receptor TrkB on astrocytes drives nitric oxide production and neurodegeneration
Q38906913Stromal contribution to the colorectal cancer transcriptome.
Q89428605The Dilemma of HER2 Double-equivocal Breast Carcinomas: Genomic Profiling and Implications for Treatment
Q33511204The GAB2 signaling scaffold promotes anchorage independence and drives a transcriptional response associated with metastatic progression of breast cancer
Q42815104The HIV-1 nef protein interferes with phosphatidylinositol 3-kinase activation 1.
Q58165024The MET oncogene drives a genetic programme linking cancer to haemostasis
Q55462084The MET oncogene is a functional marker of a glioblastoma stem cell subtype.
Q41835902The RNA-binding protein ESRP1 promotes human colorectal cancer progression
Q36090214The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis
Q44464268The miR-126 regulates angiopoietin-1 signaling and vessel maturation by targeting p85β.
Q38880745The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targets
Q42619075The tyrosine kinase receptor met and its ligand HGF are co-expressed and functionally active in HHV-8 positive primary effusion lymphoma.
Q35903618Transcriptional hallmarks of Noonan syndrome and Noonan-like syndrome with loose anagen hair.
Q37618011VEGF blockade enhances the antitumor effect of BRAFV600E inhibition.

Search more.